Gefitinib is a type of medicine used to treat cancer. Specifically, it's a targeted therapy drug that's designed to fight a certain type of cancer called non-small cell lung cancer (NSCLC). This type of cancer is one of the most common forms of lung cancer.
Now, let's break down how Gefitinib works and why it's used.
Firstly, it's important to understand that cancer cells grow and spread because they have certain proteins that tell them to do so. These proteins can be thought of as signals that keep the cancer cells multiplying and spreading throughout the body.
Gefitinib works by blocking one of these signals. It targets a protein called the epidermal growth factor receptor (EGFR). This protein is found on the surface of some cancer cells, including many NSCLC cells. When EGFR gets activated by certain substances in the body, it sends signals to the cancer cells to grow and divide. But when Gefitinib is introduced into the body, it attaches to EGFR and stops it from sending those signals. As a result, the cancer cells can't grow and multiply as they normally would.
Now, you might wonder why doctors choose Gefitinib over other treatments for NSCLC. One reason is that it's considered a targeted therapy, which means it specifically targets the cancer cells without harming too many healthy cells. This can lead to fewer side effects compared to other cancer treatments like chemotherapy, which can affect both cancerous and healthy cells.
Another reason Gefitinib is used is because it's often effective, especially in patients whose cancer has certain genetic mutations. These mutations make the cancer cells more sensitive to drugs like Gefitinib. So, if a patient's cancer has these specific mutations, Gefitinib might be a good treatment option.
However, it's important to note that Gefitinib doesn't work for everyone, and it's not a cure for cancer. Some patients may not respond to it, or their cancer may eventually become resistant to it over time. In those cases, doctors may need to explore other treatment options.
When someone is prescribed Gefitinib, they usually take it in the form of a pill that they swallow. The dosage and frequency of the medication can vary depending on factors like the patient's overall health and the stage of their cancer.
As with any medication, Gefitinib can cause side effects. Some common side effects include skin rash, diarrhea, and changes in liver function. These side effects can vary in severity from person to person, and doctors will monitor patients closely to manage any issues that arise.
In summary, Gefitinib is a targeted therapy drug used to treat non-small cell lung cancer by blocking signals that tell cancer cells to grow and multiply. It's often chosen because it can be effective with fewer side effects compared to other treatments. However, it's not a cure for cancer, and its effectiveness can vary from person to person.
Have any queries, book a consultation with our Oncology Clinical Specialist
Gefitinib
Alright, let's break down how Gefitinib works in really simple terms!
Think of cancer cells like troublemakers in your body. They grow and spread because they get signals from certain proteins, telling them to keep multiplying.
Now, Gefitinib steps in as the superhero. It targets one of these troublemaker proteins called EGFR, which is like a boss giving orders to the cancer cells. When EGFR gets activated, it tells the cancer cells to grow and divide.
But here's where Gefitinib comes in. It sneaks up and attaches itself to EGFR, blocking it from sending those growth signals. So, without those orders, the cancer cells can't grow and spread like they normally would.
Basically, Gefitinib is like the boss blocker, stopping the troublemaker proteins from making cancer cells misbehave. It's a targeted therapy, meaning it goes straight for the cancer cells while leaving most of the healthy cells alone. That's why it can be a good option for treating certain types of cancer, like non-small cell lung cancer.
Have any queries, book a consultation with our Oncology Clinical Specialist